// Contents

Muscle was long seen as a matter of appearance. Increasingly it is treated as an organ that determines metabolism, resilience to injury and independence in old age. And there is now a technological reason to say it louder: a new generation of weight-loss drugs has made doctors ask what exactly a person loses along with the weight.

Strength as a biomarker

A grip dynamometer is cheap, and the result predicts outcomes well. In the large PURE study across 17 countries (Leong et al., Lancet, 2015), weaker grip was linked to higher risk of death from all causes and from cardiovascular disease, and the association held after adjusting for age and other factors. That does not mean weak grip causes disease: it reflects overall condition. But as a cheap screening test it is useful.

With age, muscle mass and strength decline, which is called sarcopenia. The rate depends on activity and nutrition, and resistance training remains the most reliable way to slow it.

Why GLP-1 changed the conversation

Semaglutide and tirzepatide help many people lose a substantial share of their weight. But in clinical trials a notable share of the lost mass is not fat: estimates usually say roughly a quarter to a third, though exact figures depend on the drug, dose and measurement method. For a young person that is tolerable; for an older person with low baseline muscle it risks losing function along with weight.

Practical conclusions discussed in clinical guidance:

  • combine therapy with resistance training;
  • watch protein intake (individually, with a doctor);
  • track not only weight but body composition and function (strength, walking speed).

Meanwhile pharma companies are testing drugs meant to protect or build muscle during weight loss, such as myostatin and activin blockers. These are early- to mid-stage trials: none can yet be called a proven substitute for training.

What to measure and with what

  • Grip dynamometer: the most accessible test; compare with age norms.
  • Five chair stands: leg strength with no equipment.
  • Bioimpedance scales: handy for trends, but readings depend on hydration and the model; do not trust absolute numbers.
  • DEXA: a more accurate body-composition method, suitable for periodic checks on a doctor’s advice.
  • Smartwatches: estimate load indirectly; limited for strength work specifically.

A minimum program

For most adults, guidelines converge on two strength sessions a week covering the major muscle groups with gradually increasing load. What matters is progression: if weight and repetitions do not rise, the muscles have nothing to adapt to. People with heart or joint disease, osteoporosis, or those taking weight-loss drugs should consult a doctor first.

For links to nutrition and glucose sensors see our pieces on personalized nutrition and CGM .